Maynard Um
-
-
-
-
-
-
-
Tempus AI shares initial results from multimodal foundation model for oncology
-
-
-
-
-
-
-
Lucent Diagnostics partners with Tempus AI for Alzheimer's blood testing
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Raised to $95 at H.C. Wainwright
-
-
-
-
-
-
-
Tempus AI test outperforms standard biomarkers in predicting immunotherapy
-
-
-
-
-
-
-
TD Cowen Reiterates Hold Rating on Tempus AI Inc (TEM)
-
-
-
-
-
-
-
Tempus AI valuation catches up with its growth, says TD Cowen downgrading stock
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Raised to $98 at H.C. Wainwright
-
408,198 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

